CytoDyn Inc.
CYDY
$0.2265
$0.022511.03%
OTC PK
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Net Income | 60.08% | 50.14% | 266.17% | 9.92% | 13.01% |
| Total Depreciation and Amortization | -28.57% | -50.00% | -50.00% | -60.00% | -41.67% |
| Total Amortization of Deferred Charges | -82.03% | -22.07% | -83.68% | -70.45% | 5.15% |
| Total Other Non-Cash Items | -99.81% | -89.93% | -52.74% | -25.91% | -10.23% |
| Change in Net Operating Assets | -114.58% | -74.36% | -1,039.00% | 206.96% | 468.37% |
| Cash from Operations | -112.25% | -43.33% | 221.02% | 51.64% | 62.45% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | 100.00% | 36.87% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.22% | -- | -- | 153.01% | -79.92% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.42% | -100.00% | 140.53% | 154.89% | -75.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -479.91% | -94.05% | 3,273.74% | 186.86% | -84.73% |